# Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors

> **NCT01206465** · PHASE1 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 29 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** pralatrexate
- **DRUG:** fluorouracil
- **OTHER:** laboratory biomarker analysis
- **GENETIC:** DNA analysis
- **OTHER:** high performance liquid chromatography
- **GENETIC:** polymerase chain reaction
- **GENETIC:** nucleic acid sequencing
- **OTHER:** pharmacological study
- **OTHER:** pharmacogenomic studies
- **GENETIC:** polymorphism analysis

## Key facts

- **NCT ID:** NCT01206465
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-14
- **Primary completion:** 2015-02-04
- **Final completion:** 2017-06-01
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2023-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206465, "Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01206465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*